Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 3Unknown 2Recruiting 1

Sponsor Class

INDUSTRY 1INDIV 1

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Myelodysplastic Syndromes 5Lymphoma, Non-Hodgkin 5Leukemia 5Hodgkin Disease 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myeloid, Acute 4Leukemia, Myeloid, Accelerated Phase 4Leukemia, Lymphocytic, Chronic, B-Cell 4Neoplasms, Plasma Cell 3Multiple Myeloma 3Lymphoma, Mantle-Cell 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Follicular 3Graft vs Host Disease 3Congenital Abnormalities 3Recurrence 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms 2Myasthenia Gravis 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, B-Cell, Marginal Zone 2Immunoblastic Lymphadenopathy 2Hematologic Neoplasms 2Dendritic Cell Sarcoma, Interdigitating 2Burkitt Lymphoma 2Blast Crisis 2

Interventions

Pyridostigmine Bromide 4Tacrolimus 2Prednisone 2Mycophenolic Acid 2tocilizumab 1sargramostim 1Thymectomy 1Tablets 1Steroids 1Sternotomy 1Rituximab 1Methylprednisolone 1Methotrexate 1Immunosuppressive Agents 1Immunoglobulins, Intravenous 1Granulocyte-Macrophage Colony-Stimulating Factor 1Exercise 1Data Collection 1Cyclosporine 1Cyclophosphamide 1Azathioprine 1Amifampridine 1Alkalies 1Albuterol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Myasthenia Gravis × Mycophenolic Acid × Clear all
NCT04101578 2021-08-23

Clinical Prognosis and Progression of Myasthenia Gravis Patients

Da, Yuwei, M.D.

Unknown
2,000 enrolled

Myasthenia Gravis

NCT00997412 2009-10-19

Myfortic

Qualitix Clinical Research Co., Ltd.

Phase NA Unknown
40 enrolled

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡